Humira (adalimumab) is a biologic medicine that helps the pain and swelling of arthritis.
Humira is used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Juvenile Inflammatory Arthritis, Psoriasis, Crohn's Disease, and other types of arthritis. It may also be used to treat other diseases outside of rheumatology.
Humira works by blocking Tumor Necrosis Factor (TNF), a type of signalling protein (called a cytokine), that is involved in systemic inflammation. Humira belongs to a class of similar medications called Anti-Tumor Necrosis Factor agents.
Humira may be prescribed in combination with other rheumatology medications like methotrexate.
Humira is available as a subcutaneous (under the skin) injection in one of two forms that can be taken at home: as a pre-filled syringe, and as an autoinjector (pen).
Humira usually takes about 2 weeks before patients start to feel its effects. It may take 12 weeks to feel the effect of this medicine.
The manufacturer of Humira offers a support program to Canadian patients that are prescribed the medication:Patient support program enrolment forms
Important Tests and Risks
Watch Dr. Andy Thompson, a Canadian rheumatologist, introduce Humira in this short video:
Drug Identification Number (DIN)